The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer

Abstract Background Enhancer RNAs (eRNAs), the transcriptional products of active enhancers, are of great significance in the initial progression of cancers. However, the biological function and bioinformatics profiles of eRNA in gastric cancer remains largely enigmatic. Methods Firstly, STAD were c...

Full description

Bibliographic Details
Main Authors: Aiting Yan, Ying Chen, Rongrong Bian, Cuizhu Wang, Haitao Que, Yucheng Shen, Xiaomin Lu
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.4959
_version_ 1811176406452797440
author Aiting Yan
Ying Chen
Rongrong Bian
Cuizhu Wang
Haitao Que
Yucheng Shen
Xiaomin Lu
author_facet Aiting Yan
Ying Chen
Rongrong Bian
Cuizhu Wang
Haitao Que
Yucheng Shen
Xiaomin Lu
author_sort Aiting Yan
collection DOAJ
description Abstract Background Enhancer RNAs (eRNAs), the transcriptional products of active enhancers, are of great significance in the initial progression of cancers. However, the biological function and bioinformatics profiles of eRNA in gastric cancer remains largely enigmatic. Methods Firstly, STAD were clustered into three subtypes with the data of eRNA expression from TCeA. Then we explored the difference of the tumor immune microenvironment, transcription levels, and transcription regulation among the three clusters. Finally, samples collected from 12 patients diagnosed with STAD were used to conduct qRT‐PCR, verifying the conclusion based on network database. Results The three clusters were detected to have different tumor microenvironments: Cluster A has an immune “cold” microenvironment. While cluster B features as more infiltration of immune cells, accompanied with higher expression of immune checkpoints such as PDCD1, LAG3, and TIGIT. Besides, Cluster C shows a higher stromal feature with B lineage, neutrophils, and fibroblasts. Further analyses indicated that CpG island methylation level of Cluster B is different from the other two clusters. Meanwhile, Cluster A and B showed significant enrichment of TP53 and KRAS mutation respectively while Cluster C has higher tumor mutation burden (TMB) and microsatellite instability (MSI). With the elaboration of transcriptional regulation of epigenetic clustering, we detected that Cluster A enriched in epithelial phenotype pathways. Cluster B enriched in cell–cell adhesion. Cluster C enriched in fibroblast proliferation. The clinical cohort show that Cluster B patients have lower interstitial cell characteristics and CAF infiltration. Conclusion We identified three unique epigenetic clusters of STAD through the differential activation of super‐enhancers, and identified Cluster B with a higher immune infiltrating and a better prognosis, which provides a novel understanding of eRNAs and potential clinical applicability of eRNA‐based molecular subtypes in gastric cancer.
first_indexed 2024-04-10T19:52:04Z
format Article
id doaj.art-c1af47b9bf4648919a6c221eb316ee58
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-10T19:52:04Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-c1af47b9bf4648919a6c221eb316ee582023-01-28T05:30:05ZengWileyCancer Medicine2045-76342023-01-011222046205710.1002/cam4.4959The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancerAiting Yan0Ying Chen1Rongrong Bian2Cuizhu Wang3Haitao Que4Yucheng Shen5Xiaomin Lu6Department of Oncology Affiliated Haian Hospital of Nantong University Nantong Jiangsu ChinaDepartment of Oncology The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third people's hospital Yancheng Jiangsu ChinaDepartment of Oncology, Nanjing Liuhe People Hospital Nanjing Jiangsu ChinaDepartment of Oncology Affiliated Haian Hospital of Nantong University Nantong Jiangsu ChinaDepartment of Oncology Affiliated Haian Hospital of Nantong University Nantong Jiangsu ChinaDepartment of Oncology Affiliated Haian Hospital of Nantong University Nantong Jiangsu ChinaDepartment of Oncology Affiliated Haian Hospital of Nantong University Nantong Jiangsu ChinaAbstract Background Enhancer RNAs (eRNAs), the transcriptional products of active enhancers, are of great significance in the initial progression of cancers. However, the biological function and bioinformatics profiles of eRNA in gastric cancer remains largely enigmatic. Methods Firstly, STAD were clustered into three subtypes with the data of eRNA expression from TCeA. Then we explored the difference of the tumor immune microenvironment, transcription levels, and transcription regulation among the three clusters. Finally, samples collected from 12 patients diagnosed with STAD were used to conduct qRT‐PCR, verifying the conclusion based on network database. Results The three clusters were detected to have different tumor microenvironments: Cluster A has an immune “cold” microenvironment. While cluster B features as more infiltration of immune cells, accompanied with higher expression of immune checkpoints such as PDCD1, LAG3, and TIGIT. Besides, Cluster C shows a higher stromal feature with B lineage, neutrophils, and fibroblasts. Further analyses indicated that CpG island methylation level of Cluster B is different from the other two clusters. Meanwhile, Cluster A and B showed significant enrichment of TP53 and KRAS mutation respectively while Cluster C has higher tumor mutation burden (TMB) and microsatellite instability (MSI). With the elaboration of transcriptional regulation of epigenetic clustering, we detected that Cluster A enriched in epithelial phenotype pathways. Cluster B enriched in cell–cell adhesion. Cluster C enriched in fibroblast proliferation. The clinical cohort show that Cluster B patients have lower interstitial cell characteristics and CAF infiltration. Conclusion We identified three unique epigenetic clusters of STAD through the differential activation of super‐enhancers, and identified Cluster B with a higher immune infiltrating and a better prognosis, which provides a novel understanding of eRNAs and potential clinical applicability of eRNA‐based molecular subtypes in gastric cancer.https://doi.org/10.1002/cam4.4959eRNAsgastric cancerimmune microenvironmentmethylationmutation
spellingShingle Aiting Yan
Ying Chen
Rongrong Bian
Cuizhu Wang
Haitao Que
Yucheng Shen
Xiaomin Lu
The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
Cancer Medicine
eRNAs
gastric cancer
immune microenvironment
methylation
mutation
title The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
title_full The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
title_fullStr The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
title_full_unstemmed The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
title_short The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer
title_sort landscape of enhancer rna identify prognosis related molecular subtypes in gastric cancer
topic eRNAs
gastric cancer
immune microenvironment
methylation
mutation
url https://doi.org/10.1002/cam4.4959
work_keys_str_mv AT aitingyan thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT yingchen thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT rongrongbian thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT cuizhuwang thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT haitaoque thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT yuchengshen thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT xiaominlu thelandscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT aitingyan landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT yingchen landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT rongrongbian landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT cuizhuwang landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT haitaoque landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT yuchengshen landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer
AT xiaominlu landscapeofenhancerrnaidentifyprognosisrelatedmolecularsubtypesingastriccancer